Catheter Precision Shareholders Approve Key Corporate Changes

Catheter Precision (VTAK) has shared an update.

Catheter Precision, Inc. stockholders showed active participation in their annual meeting where they approved several key proposals, including the issuance of an additional two million shares for the company’s 2023 Equity Incentive Plan, amendments to the corporate charter to decrease authorized stock and to enable a reverse stock split, as well as the election of directors and decisions on executive compensation practices. Shareholders also ratified the appointment of the company’s accounting firm, reflecting a proactive approach to corporate governance and management’s incentive alignment with long-term growth.

For an in-depth examination of VTAK stock, go to TipRanks’ Stock Analysis page.